LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (the “Company”) (AMEX: RVP), a leading maker of safety needle medical devices, reported revenues of $10.8 million for the three months ended September 30, 2009, an increase of 19.5% over the same period in 2008. The increase in total revenues from the year-ago quarter was partially due to the sales generated as a result of the Company’s selection by the U.S. Department of Health & Human Services (“DHHS”) as one of the providers of safety syringes for swine flu vaccinations. An increase in gross profit was attributed primarily to higher revenues and lower unit cost of production. The average cost of manufactured product sold decreased 5.4% per unit due to higher volumes. Loss from operations increased due principally to increased litigation costs and stock option expense, mitigated by a higher gross profit.
